e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Post-transplant complications: from pathogenesis to treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
NFkB location in T-cells is promising to monitor immunosuppression after lung transplantation
U. Sommerwerck, M. Lindemann, B. E. Kleibrink, T. Rabis, G. Weinreich, M. Kamler, H. Teschler, P. A. Horn, V. Rebmann (Essen, Germany)
Source:
International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Session:
Post-transplant complications: from pathogenesis to treatment
Session type:
Poster Discussion
Number:
3309
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Sommerwerck, M. Lindemann, B. E. Kleibrink, T. Rabis, G. Weinreich, M. Kamler, H. Teschler, P. A. Horn, V. Rebmann (Essen, Germany). NFkB location in T-cells is promising to monitor immunosuppression after lung transplantation. Eur Respir J 2014; 44: Suppl. 58, 3309
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Special issues in elderly people with solitary pulmonary nodule: non intubated thoracic surgery
Lung transplantation
Severe haemoptysis
Related content which might interest you:
The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Hypogammaglobulinemia in lung transplant candidates
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Long-term outcome of lung recipients: The role of CD4+CD25highCD127- treg
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Tacrolimus increases inflammatory cells in lung
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
Effects of two immunosuppressive triple therapies on inflammatory cells in lung
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
The influence of extracorporeal photopheresis on NFκB signaling and cytokine expression in lung transplant patients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Effect of extracorporeal photopheresis on respiratory function in hematopoietic stem cell transplant recipients
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Infectious complications after lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193
Year: 2003
Pulmonary function changes following allogeneic haematopoietic cell transplantation
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Prostacyclin and VEGF in the rejection process after lung transplantation – A possible biomarker
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
LATE-BREAKING ABSTRACT: Long-term survival with extracorporeal photochemotherapy in lung transplant rejection patients not responsive to conventional treatment.
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx)
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Pulmonary function testing pre and after allogeneic hematopoietic cell transplantation for hematological malignancies
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
Serum cytokines patterns in lung transplant recipients
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015
Lung transplantation
Source: Respipedia Article
Year: 2019
Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
A new lung donor scoring system
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Early sirolimus immunosuppression is safe in lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept